top of page
Back

SANOFI INDIA - ALLEGRA
IN-CLINIC ENGAGEMENT CAMPAIGN FOR ALLEGRA BY SANOFI PHARMA 

Background: Sanofi Pharma's antihistamine drug, Allegra, is a leading solution for managing allergies. With its endorsement in the renowned Flexpolar Study for Allergic Rhinitis, Sanofi identified an opportunity to position Allegra 180 as an effective treatment for allergies, particularly in cases linked to pollution. This campaign was aimed at creatively communicating the drug’s efficacy and connecting it to real-world scenarios relevant to the Indian healthcare context. 

Objective: To leverage insights from the Flexpolar Study and establish Allegra 180 as a trusted solution for allergy management through targeted in-clinic engagement and integrated marketing communication campaigns. 

Sanofi Allegra print advertisement campaign design – Pavan Java Studio Mumbai

SERVICES

Campaign Design, In-Clinic Activations & Engagements at HCP's

STRATEGY 

Sanofi's comprehensive approach combined in-clinic engagement and an integrated marketing communication campaign: 

Integrated Communication Campaign: To bridge the gap between pollution and allergies, a multi-channel campaign was crafted. This initiative emphasized: 

  1. The role of Allegra 180 in managing allergies caused by pollution. 

  2. Clinical evidence from the Flexpolar Study supporting its efficacy for Allergic Rhinitis. 

  3. Targeted communication to healthcare professionals (HCPs) and patients that highlighted Allegra’s capabilities. 

Direct HCP Outreach: Medical Representatives (MRs) visited clinics to present the Flexpolar Study findings in engaging formats, focusing on: 

  1. The drug's safety and efficacy profile. 

  2. Real-world applications relevant to allergy management in polluted urban environments. 

Patient-Focused Collateral: Informational posters, pamphlets, and creative in-clinic materials were deployed, aiming to: 

  1. Educate patients about allergy symptoms and the link to pollution. 

  2. Promote discussions between patients and doctors about appropriate treatment options like Allegra 180. 

EXECUTION 

Sanofi’s Medical Representatives employed interactive presentations, visual storytelling, and data-backed insights to resonate with HCPs. Simultaneously, clinics showcased prominently designed educational materials, reinforcing Allegra’s value to patients and caregivers.

Sanofi Allegra campaign tagline for pollution-driven allergic rhinitis communication – Pavan Java Studio Mumbai

CAMPAIGN TAGLINES

Sanofi Allegra leaflet folder design for HCP in-clinic – Pavan Java Studio Mumbai
Sanofi Allegra leaflet folder with Flexpolar Study clinical data – Pavan Java Studio Mumbai

LEAVE BEHIND LEAFLET WITH COVER

Sanofi Allegra in-clinic waiting room poster design for allergy awareness and patient education – Pavan Java Studio Mumbai

CLINIC POSTERS

Sanofi Allegra awareness campaign print advertisement for pollution-triggered allergy treatment India – Pavan Java Studio Mumbai

AWARENESS CAMPAIGNS 

DIRECT MAILERS/LBL

IN-CLINIC ENGAGEMENT

Results:

  • Positioned Allegra 180 as a leading choice for allergy management, particularly in urban and pollution-prone contexts. 

  • Strengthened awareness among HCPs regarding Allegra's clinical backing and unique capabilities. 

  • Enhanced patient understanding of allergies, leading to more informed consultations. 

  • Contributed to a measurable increase in Allegra prescriptions and sales. 

Conclusion:

This campaign highlighted the power of combining clinical evidence like the Flexpolar Study with strategic communication initiatives. By connecting pollution-driven allergies to a proven treatment like Allegra 180, Sanofi Pharma demonstrated how creative, targeted efforts could engage both HCPs and patients effectively. This success underscores the importance of leveraging innovative marketing strategies in healthcare. 

PROVEN RESULTS

Clinical evidence. Pollution-era relevance. A campaign that made Allegra the obvious choice.

Sanofi's brief was to leverage the Flexpolar Study findings to position Allegra 180 as the leading antihistamine for pollution-driven allergies in India. We designed a fully integrated in-clinic and multi-channel campaign that translated clinical data into compelling creative communication for both HCPs and patients.

1

CLINICAL STUDY

ACTIVATED

Flexpolar Study allergic rhinitis data

5+

COLLATERAL TYPES DEPLOYED

LBL, posters, print ads, direct mailers, in-clinic

2

AUDIENCES

ACTIVATED

HCPs via MR visits and patients via clinic materials

What We Delivered

  • The Flexpolar Study findings were translated from clinical data into accessible, visually compelling communication — making complex evidence usable at the point of prescription.

  • In-clinic engagement materials created a dual impact: Medical Representatives used them during HCP visits, while clinic posters simultaneously educated patients in waiting rooms.

  • The campaign directly linked the urban pollution narrative to allergy symptoms and Allegra's mechanism — making the product feel urgently relevant to an Indian metropolitan audience.

  • A measurable increase in Allegra prescriptions and sales was achieved — demonstrating that creative work grounded in clinical evidence drives real commercial outcomes.

Pharmaceutical marketing works when clinical rigour and creative storytelling operate together — not in separate silos. We are fluent in both, and the prescription data is the proof.

© Copyright Pavan Java Studio No material or information from this presentation may be copied, reproduced, republished, uploaded, posted, transmitted or distributed except as authorized in the terms of use, expressly authorized/approved in writing by Imperial Graphics Studio.

bottom of page